For Immediate Release
February 28, 2022

Calgary, Alberta – Delta CleanTech Inc. (“Delta” or the “Company”) (CSE:DELT, FRA: 66C ,OTCQB:DCTIF) along with Carbon RX announced today that it would be a feature speaker at the – Gravitas’ 5th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel and also virtually on Thursday, March 3, 2022, in Vancouver, British. Last year was incredibly successful (see video highlights here), with 15 presenting companies, 350+ active guests in person and virtual, and over 10,000+ virtual interactions.

Delta’s Chairman, Mr. Lionel Kambeitz, will present Delta’s latest CO2 capture and solvent reclamation technology and business initiatives to an audience of retail, venture capital, family office, and institutional investors. Delta will be highlighted as one the very best emerging businesses in the Environmental, Social and Governance (ESG) CleanTech growth space.

Mr. Kambeitz will also introduce Carbon RX in his presentation. Carbon RX originates, validates fidelity, certifies, and registers voluntary carbon credits that will incorporate legacy & new industrial processes with technologies which will require Carbon RX’s carbon credit fidelity validation and tokenization platform utilizing block chain technology.

If you are interested in attending, please register at www.Gravitas5thAnnual.com to secure your spot at this second to none world class event.

About Delta CleanTech Inc.
Delta CleanTech Inc. is a 15-year ESG-driven, recognized global technology leader in CO2 Capture, Decarbonization of Energy, Solvent & Glycol Reclamation, Blue Hydrogen Production, and Carbon Credit Aggregation and Management. Delta continues to provide solutions to clients all over the world in sequestering, capturing, and reducing CO2 and through its Carbon RX wholly owned subsidiary is originating, validating, tokenizing, and streaming Carbon Credits.

About Carbon RX Inc.
CarbonRX Inc. (“Carbon RX”), was founded in 2006 and is a wholly owned subsidiary of Delta CleanTech Inc. and an historic North American leader in the origination, validation, and streaming of voluntary Carbon Credits. Carbon RX is again leading the industry in utilizing its proprietary decarbonization and GHG mitigation technologies to originate high fidelity Carbon Credits and is leveraging blockchain technology to tokenize and add more security and higher value to this asset class.

For media inquiries
Jeff Allison, President
Phone: 306‐352-6132
Cell: 306-530-6025
E‐mail: jallison@deltacleantech.ca

Forward Looking Statements
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, which is based on Carbon RX’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. All statements other than statements of historical fact are forward-looking information. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “might”, “will”, “shall”, “should”, “intend”, “anticipate”, “project”, “contemplate”, “continue”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. No assurance can be given that these expectations will prove to be correct and such forward-looking information included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. Carbon RX does not undertake any obligations to publicly update or revise any forward-looking information except as required by securities law.

The CSE does not accept responsibility for the adequacy or accuracy of this release.